The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders

Claudia K Y Lai, Claudia K Y Lai

Abstract

Objective: The Neuropsychiatric Inventory (NPI) is one of the most commonly used assessment scales for assessing symptoms in people with dementia and other neurological disorders. This paper analyzes its conceptual framework, measurement mode, psychometric properties, and merits and problems.

Method: All articles discussing the psychometric properties and factor structure of the NPI were searched for in Medline via Ovid. The abstracts of these papers were read to determine their relevance to the purpose of this paper. If deemed appropriate, a full paper was then obtained and read.

Results: The NPI has reasonably good content validity and internal consistency, and good test-retest and interrater reliability. There is limited information about its sensitivity, specificity, positive and negative predictive values, and, in particular, responsiveness. Merits of the NPI include being comprehensive, avoiding symptom overlap, ease of use, and flexibility. It has problems in scoring (no multiples of 5, 7, and 11) and, therefore, analysis using parametric tests may not be appropriate. The use of individual subscales also warrants further investigation.

Conclusion: In terms of its content and concurrent validity, intra- and interrater reliability, test-retest reliability, and internal consistency, the NPI can be considered as valid and reliable, and can be used across different ethnic groups. The tool is most likely unable to deliver as good a performance in terms of discriminating between different disorders. More studies are required to further evaluate its psychometric properties, particularly in the areas of factor structure and responsiveness. The clinical utility of the NPI also needs to be further explored.

Keywords: measurement; neuropsychiatric symptoms; outcome assessment.

References

    1. Conn D, Thorpe L. Assessment of behavioral and psychological symptoms associated with dementia. Can J Neurol Sci. 2007;34(Suppl 1):S67–S71.
    1. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–2314.
    1. Lange RT, Hopp GA, Kang N. Psychometric properties and factor structure of the Neuropsychiatric Inventory Nursing Home version in an elderly neuropsychiatric population. Int J Geriatr Psychiatry. 2004;19(5):440–448.
    1. McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D. Neuropsychiatric problems in Parkinson’s disease: comparisons between self and caregiver report. Aging Ment Health. 2008;12(5):647–653.
    1. Krishnamoorthy ES, Trimble MR. Prevalence, patterns, service needs, and assessment of neuropsychiatric disorders among people with epilepsy in residential care: validation of the Neuropsychiatric Inventory as a caregiver-rated measure of neuropsychiatric functioning in epilepsy. Epilepsy Behav. 2008;13(1):223–228.
    1. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5 Suppl 6):S10–S16.
    1. Connor DJ, Sabbagh MN, Cummings JL. Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials. Alzheimers Dement. 2008;4(6):390–394.
    1. Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–239.
    1. Wood S, Cummings JL, Hsu MA, et al. The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry. 2000;8(1):75–83.
    1. Kane RL, Radosevich DM. Conducting Health Outcomes Research. Sudbury, MN: Jones & Bartlett Learning; 2011.
    1. Kang SJ, Choi SH, Lee BH, et al. Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI) J Geriatric Psychiatry Neurol. 2004;17(1):32–35.
    1. Reisberg B, Auer SR, Monteiro IM. Behavioral Pathology in Alzheimer’s Disease (BEHAVE-AD) Rating Scale. Int Psychogeriatr. 1996;8(Suppl 3):301–308.
    1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
    1. Leung VP, Lam LC, Chiu HF, Cummings JL, Chen QL. Validation study of the Chinese version of neuropsychiatric inventory (CNPI) Int J Geriatr Psychiatry. 2001;16:789–793.
    1. Fernandez HH, Aarsland D, Fénelon G, et al. Scales to assess psychosis in Parkinson’s disease: Critique and recommendations. Mov Disord. 2008;23(4):484–500.
    1. Tractenberg RE, Singer CM, Cummings JL, Thal LJ. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer’s disease. J Sleep Res. 2003;12:331–337.
    1. Nagahama Y, Okina T, Suzuki N, Matsuda M. The Cambridge Behavioral Inventory: validation and application in a memory clinic. J Geriatr Psychiatry Neurol. 2006;19:220–225.
    1. Dechamps A, Jutand MA, Onifade C, Richard-Harston, Bourdel-Marchasson I. Co-occurrence of neuropsychiatric syndromes in demented and psychotic institutionalized elderly. Int J Geriatr Psychiatry. 2008;23(11):1182–1190.
    1. Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Neuropsychiatric symptoms in nursing home patients: factor structure invariance of the Dutch Nursing Home version of the Neuropsychiatric Inventory in different stages of dementia. Dement Geriatr Cogn Disord. 2007;24:169–176.
    1. Perrault A, Oremus M, Demers L, Vida S, Woflson C. Review of outcome measurement instruments in Alzheimer’s disease drug trials: psychometric properties of behavior and mood scales. J Geriatr Psychiatry Neurol. 2000;13(4):181–196.
    1. Ismail Z, Emeremni MA, Houck PR, et al. A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia. Am J Geriatr Psychiatry. 2013;21(1):78–87.
    1. Cummings JL, McPherson S. Neuropsychiatric assessment of Alzheimer’s disease and related dementias. Aging (Milano) 2001;13(3):240–246.
    1. Frisoni GB, Rozzini L, Gozzetti A, et al. Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Disord. 1999;10(2):130–138.
    1. Kaufer D. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer’s disease. Dement Geriatr Cogn Disord. 1998;9(Suppl 2):8–14.
    1. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer’s disease. Neurology. 1996;46:130–135.
    1. Morris JC, Cyrus PA, Orazem J, et al. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer’s disease. Neurology. 1998;50(5):1222–1230.
    1. Rocha FL, Hara C, Ramos MG, et al. An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia. Dement Geriatr Cogn Disord. 2006;22(5–6):445–448.
    1. Hama S, Yamashita H, Shigenobu M, et al. Depression or apathy and functional recovery after stroke. Int J Geriatr Psychiatry. 2007;22(10):1046–1051.
    1. Holmes C, Wilkinson D, Dean C, et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology. 2004;63(2):214–219.
    1. Scripnikov A, Khomenko A, Napryeyenko O. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial. Wien Med Wochenschr. 2007;157(13–14):295–300.
    1. Aalten P, Verhey FR, Boziki M, et al. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord. 2007;24(6):457–463.
    1. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol. 1998;55(10):1313–1319.
    1. Blair M, Kertesz A, Davis-Faroque N, et al. Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the Frontal Behavioural Inventory and the Neuropsychiatric Inventory in a national cohort study. Dement Geriatr Cogn Disord. 2007;23:406–415.
    1. Fuh JL, Lam L, Hirono N, Senanarong V, Cummings JL. Neuropsychiatric Inventory workshop: behavioral and psychologic symptoms of dementia in Asia. Alzheimer Dis Assoc Disord. 2006;20(4):314–317.
    1. Chow TW, Liu CK, Fuh JL, et al. Neuropsychiatric symptoms of Alzheimer’s disease differ in Chinese and American patients. Int J Geriatr Psychiatry. 2002;17(1):22–28.
    1. Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2005;76(10):1337–1341.
    1. Gallo JL, Schmidt KS, Libon DJ. An itemized approach to assessing behavioral and psychological symptoms in dementia. Am J Alzheimers Dis Other Demen. 2009;24(2):163–168.
    1. Leontjevas R, Van Hooren S, Mulders A. The Montgomery-Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: a validation study with patients exhibiting early-onset dementia. Am J Geriatr Psychiatry. 2009;17(1):56–64.
    1. Cohen-Mansfield J. Heterogeneity in dementia: Challenges and opportunities. Alzheimer Dis Assoc Disord. 1999;14(2):60–63.
    1. Aalten P, Verhey FR, Boziki M, et al. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord. 2008;25(1):1–8.
    1. Hirono N, Mori E, Yasuda M, et al. Factors associated with psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg and Psychiatry. 1998;64(5):648–652.
    1. Matsui T, Nakaaki S, Murata Y, et al. Determinants of the quality of life in Alzheimer’s disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer’s disease scale. Dement Geriatr Cogn Disord. 2006;21(3):182–191.
    1. Lam CL, Chan WC, Mok CC, Li S, Lam LC. Validation of the Chinese Challenging Behaviour Scale: clinical correlates of challenging behaviours in nursing home residents with dementia. Int J Geriatr Psychiatry. 2006;21(8):792–799.
    1. Selbaek G, Kirkevold O, Sommer OH, Engedal K. The reliability and validity of the Norwegian version of the Neuropsychiatric Inventory, nursing home version (NPI-NH) Int Psychogeriatr. 2008;20(2):375–382.
    1. Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Predictors of neuropsychiatric symptoms in nursing home patients: influence of gender and dementia severity. Int J Geriatr Psychiatry. 2009;24(10):1079–1086.
    1. Lam LC, Tam CW, Lui VW, et al. Prevalence of very mild and mild dementia in community-dwelling older Chinese people in Hong Kong. Int Psychogeriatr. 2008;20(1):135–148.
    1. Fuh JL, Liu CK, Mega MS, Wang SJ, Cummings JL. Behavioral disorders and caregivers’ reaction in Taiwanese patients with Alzheimer’s disease. Int Psychogeriatr. 2001;13(1):121–128.
    1. Aalten P, De Vugt ME, Lousberg R, et al. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord. 2003;15(2):99–105.
    1. Mirakhur A, Craig D, Hart DJ, McLlroy SP, Passmore AP. Behavioural and psychological syndromes in Alzheimer’s disease. Int J Geriatr Psychiatry. 2004;19(11):1035–1039.
    1. Spalletta G, Baldinetti F, Buccione I, et al. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer’s disease. J Neurol. 2004;251(6):688–695.
    1. Matsumoto N, Ikeda M, Fukuhara R, et al. Neuropsychiatric Inventory Caregiver Distress Scale (NPI-D) and Japanese Version of the Neuropsychiatric Inventory-Brief Questionnaire Form (NPI-Q). Abstracts of the 20th Annual Meeting of the Japanese Psychogeriatric Society. Psychogeriatrics. 2005;5(4):A79–A80.
    1. Kilmer RP, Demakis GJ, Hammond FM, Grattan KE, Cook JR, Kornev AA. Use of the neuropsychiatric inventory in traumatic brain injury: a pilot investigation. Rehabil Psychol. 2006;51(3):232–238.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться